GPR171 (Gene)

Organism:

Homo sapiens

Synonyms:ENTREZ:29909, G protein-coupled receptor 171, GPR171, H963, HGNC:30057, MIM:618925, NM_013308, NP_037440, XM_005247402, XM_005247403, XM_017006274, XP_005247459, XP_005247460, XP_016861763

Omim:OMIM:618925

Id:27de5931-58d0-57e9-a0cb-22561daa5573

Hgnc:HGNC:30057

Entrez:29909

Ensembl:ENSG00000174946

Description:G protein-coupled receptor 171

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View GPR171's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with GPR171.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using GPR171.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for GPR171.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GPR171.

Results found

Linked to

	Label	Description
	GSE115384 CELSR2 knockdown 2 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE188570 GSE188571 decitabine 5 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE245677 CDK2 inhibition 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE162892 ISOX 4 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE103122 puromycin 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE182150 KIT LSD1 MYC inhibition 6 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE237216 STAT1 knockout RPMI-8226 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE114492 GSE153671 KMT2D inhibition 10 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE207611 GSE207612 cisplatin 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE58724 1 V 0 OXYMETHOLONE MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS

GSE115384 CELSR2 knockdown 2 v 7 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE188570 GSE188571 decitabine 5 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE245677 CDK2 inhibition 2 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE162892 ISOX 4 v 5 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE103122 puromycin 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE182150 KIT LSD1 MYC inhibition 6 v 7 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE237216 STAT1 knockout RPMI-8226 2 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE114492 GSE153671 KMT2D inhibition 10 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE207611 GSE207612 cisplatin 3 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE58724 1 V 0 OXYMETHOLONE MOUSE UP

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.